EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment

Binay Kumar Shah iD, Bivek Singh iD, Yukun Wang iD, Shuanshuan Xie iD, Changhui Wang iD

Mediators of Inflammation · 06.07.2023 · 2023 · 1-15

DOI: 10.1155/2023/8840594 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, erschienen am 06.07.2023. Verfasst von Binay Kumar Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China. Hauptthemen laut MEDLINE: Cough, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most patients diagnosed with chronic obstructive pulmonary disease (COPD) present with hallmark features of airway mucus hypersecretion, including cough and expectoration. Airway mucus function as a native immune system of the lung that severs to trap particulate matter and pathogens and allows them to clear from the lung via cough and ciliary transport. Chronic mucus hypersecretion (CMH) is the main factor contributing to the increased risk of morbidity and mortality in specific subsets of COPD patients. It is, therefore, primarily important to develop medications that suppress mucus hypersecretions in these patients. Although there have been some advances in COPD treatment, more work remains to be done to better understand the mechanism underlying airway mucus hypersecretion and seek more effective treatments. This review article discusses the structure and significance of mucus in the lungs focusing on gel-forming mucins and the impacts of CMH in the lungs. Furthermore, we summarize the article with pharmacological and nonpharmacological treatments as well as novel and interventional procedures to control CMH in COPD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoughPulmonary Disease, Chronic ObstructiveHumansMucusLungSputum

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
  • Tongji University School of Medicine, Shanghai 200092, China.

ORCID-Profile: Binay Kumar Shah, Bivek Singh, Yukun Wang, Shuanshuan Xie, Changhui Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shah, B. K., Singh, B., Wang, Y., Xie, S., & Wang, C. (2023). Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment. Mediators of Inflammation, 2023, 1-15. https://doi.org/10.1155/2023/8840594

Vancouver

Shah BK, Singh B, Wang Y, Xie S, Wang C. Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment. Mediators of Inflammation. 2023;2023:1-15. doi:10.1155/2023/8840594

BibTeX
@article{Shah2023,
  author = {Shah, Binay Kumar and Singh, Bivek and Wang, Yukun and Xie, Shuanshuan and Wang, Changhui},
  title = {Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment},
  journal = {Mediators of Inflammation},
  year = {2023},
  volume = {2023},
  pages = {1--15},
  doi = {10.1155/2023/8840594}
}
Kostenlos starten →